Details for New Drug Application (NDA): 019527
✉ Email this page to a colleague
The generic ingredient in PEPCID is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
Summary for 019527
Tradename: | PEPCID |
Applicant: | Salix Pharms |
Ingredient: | famotidine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019527
Suppliers and Packaging for NDA: 019527
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PEPCID | famotidine | FOR SUSPENSION;ORAL | 019527 | NDA AUTHORIZED GENERIC | Padagis US LLC | 0574-0147 | 0574-0147-04 | 50 mL in 1 BOTTLE (0574-0147-04) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Feb 2, 1987 | TE: | RLD: | Yes |
Expired US Patents for NDA 019527
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Salix Pharms | PEPCID | famotidine | FOR SUSPENSION;ORAL | 019527-001 | Feb 2, 1987 | 4,283,408*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription